REAL-WORLD IMPACT OF TRIPLE THERAPY WITH FLUTICASONE FUROATE, UMECLIDINIUM, AND VILANTEROL ON ASTHMA CONTROL AMONG US PATIENTS WITH ASTHMA

被引：0
|
作者：
Bogart, Michael
Germain, Guillaume
Laliberte, Frakois
Mahendran, Malena
Duh, Mei S.
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1598
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1930A / 1931A
页数：2
相关论文
共 50 条
  • [31] ARE PATIENTS WITH COPD MORE ADHERENT TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) COMPARED WITH MULTIPLE-INHALER TRIPLE THERAPY IN A REAL-WORLD UK PRIMARY CARE TREATED POPULATION?
    Halpin, D. M. G.
    Rothnie, K. J.
    Banks, V.
    Czira, A.
    Compton, C.
    Wood, R.
    Tritton, T.
    Massey, O.
    Wild, R.
    Snowise, N.
    Gubba, E.
    Sharma, R.
    Ismaila, A. S.
    Vogelmeier, C. F.
    THORAX, 2021, 76 : A20 - A21
  • [32] Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction
    Martin, Neil
    Weiler, John M.
    Pearlman, David
    Jacques, Loretta
    Nunn, Carol
    Forth, Richard
    West, Sarah
    Dunn, Karen
    O'Byrne, Paul M.
    JOURNAL OF ASTHMA, 2020, 57 (04) : 431 - 440
  • [33] Real-life effectiveness of fluticasone furoate/vilanterol after switching from fluticasone/salmeterol or budesonide/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)
    Shimizu, Yasuo
    Shiobara, Taichi
    Arai, Ryo
    Chibana, Kazuyuki
    Takemasa, Akihiro
    JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 1877 - 1883
  • [34] Population pharmacokinetics of inhaled fluticasone furoate and vilanterol in adult and adolescent patients with asthma
    Allen, Ann
    Siederer, Sarah
    Yang, Shuying
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (04) : 269 - 281
  • [35] Triple Therapy of Fluticasone Furoate, Umeclidinium, Vilanterol- A Compelling Choice in Severe Chronic Obstructive Pulmonary Disease
    Nathan, B. Jagan
    Sahay, Melina, I
    Gautham, A. K.
    Sriram, D. K.
    George, Melvin
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (02) : CP7 - CP7
  • [36] Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
    Pelaia, Corrado
    Procopio, Giada
    Deodato, Maria Rosaria
    Florio, Olivia
    Maglio, Angelantonio
    Sciacqua, Angela
    Vatrella, Alessandro
    Pelaia, Girolamo
    RESPIRATION, 2021, 100 (02) : 127 - 134
  • [37] Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung Study
    Jacques, Loretta
    Bakerly, Nawar Diar
    New, John P.
    Svedsater, Henrik
    Lay-Flurrie, James
    Leather, David A.
    JOURNAL OF ASTHMA, 2019, 56 (07) : 748 - 757
  • [38] Real-World Assessment of Asthma Specialist Visits Among US Patients with Severe Asthma
    Most, Jessica F.
    Ambrose, Christopher S.
    Chung, Yen
    Kreindler, James L.
    Near, Aimee
    Brunton, Stephen
    Cao, Yao
    Huang, Huan
    Zhao, Xiaohui
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10): : 3662 - +
  • [39] COST-EFFECTIVENESS OF FLUTICASONE FUROATE PLUS VILANTEROL ON ASTHMA CONTROL IN CLINICAL PRACTICE
    Vaidya, Anil
    Davies, Andrew
    Johnston, Karissa
    Powell, Lauren
    Lay-Flurrie, James
    Svedsater, Henrik
    CHEST, 2018, 154 (04) : 1136A - 1137A
  • [40] Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN)
    Yang, Shuying
    Lee, Laurie A.
    Sule, Neal
    Fowler, Andrew
    Peachey, Guy
    CLINICAL PHARMACOKINETICS, 2021, 60 (07) : 887 - 896
12345